A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Insmed Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 50,000 shares of INSM stock, worth $3.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,000
Previous 59,200 15.54%
Holding current value
$3.73 Million
Previous $1.83 Million 26.06%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$19.86 - $26.93 $317 - $430
16 New
16 $0
Q1 2023

May 15, 2023

SELL
$16.26 - $21.73 $21 Million - $28.1 Million
-1,291,580 Closed
0 $0
Q4 2022

Feb 14, 2023

SELL
$16.98 - $23.15 $4.24 Million - $5.79 Million
-249,894 Reduced 16.21%
1,291,580 $25.8 Million
Q3 2022

Nov 14, 2022

SELL
$20.88 - $28.21 $2.49 Million - $3.37 Million
-119,380 Reduced 7.19%
1,541,474 $33.2 Million
Q2 2022

Aug 15, 2022

SELL
$17.07 - $25.71 $12 Million - $18.1 Million
-703,806 Reduced 29.76%
1,660,854 $32.8 Million
Q1 2022

May 16, 2022

SELL
$20.42 - $28.13 $706,368 - $973,072
-34,592 Reduced 1.44%
2,364,660 $55.6 Million
Q4 2021

Feb 14, 2022

SELL
$25.89 - $33.45 $30.9 Million - $39.9 Million
-1,192,736 Reduced 33.21%
2,399,252 $65.4 Million
Q3 2021

Nov 15, 2021

BUY
$22.46 - $29.47 $16.1 Million - $21.1 Million
716,392 Added 24.91%
3,591,988 $98.9 Million
Q2 2021

Aug 16, 2021

SELL
$24.17 - $36.01 $39,300 - $58,552
-1,626 Reduced 0.06%
2,875,596 $81.8 Million
Q1 2021

May 17, 2021

BUY
$32.28 - $44.3 $83.8 Million - $115 Million
2,597,121 Added 927.21%
2,877,222 $98 Million
Q4 2020

Feb 16, 2021

SELL
$31.45 - $40.54 $768,952 - $991,203
-24,450 Reduced 8.03%
280,101 $9.33 Million
Q3 2020

Nov 16, 2020

BUY
$26.0 - $34.5 $6.83 Million - $9.07 Million
262,874 Added 630.74%
304,551 $9.79 Million
Q2 2020

Aug 14, 2020

SELL
$14.11 - $29.42 $46.4 Million - $96.7 Million
-3,286,999 Reduced 98.75%
41,677 $1.15 Million
Q1 2020

May 15, 2020

BUY
$13.63 - $33.98 $42.1 Million - $105 Million
3,087,841 Added 1282.14%
3,328,676 $53.4 Million
Q4 2019

Feb 14, 2020

SELL
$16.12 - $24.98 $7.6 Million - $11.8 Million
-471,654 Reduced 66.2%
240,835 $5.75 Million
Q3 2019

Nov 15, 2019

SELL
$15.49 - $25.78 $538,695 - $896,551
-34,777 Reduced 4.65%
712,489 $12.6 Million
Q2 2019

Aug 14, 2019

BUY
$23.0 - $32.19 $15.5 Million - $21.7 Million
675,166 Added 936.43%
747,266 $19.1 Million
Q1 2019

May 15, 2019

SELL
$13.91 - $31.15 $3.38 Million - $7.57 Million
-243,050 Reduced 77.12%
72,100 $2.1 Million
Q4 2018

Feb 14, 2019

SELL
$11.6 - $18.7 $3.88 Million - $6.25 Million
-334,150 Reduced 51.46%
315,150 $4.14 Million
Q3 2018

Nov 14, 2018

BUY
$18.95 - $28.08 $12.3 Million - $18.2 Million
649,300 New
649,300 $13.1 Million
Q4 2017

Feb 14, 2018

SELL
$26.43 - $31.78 $2.92 Million - $3.51 Million
-110,410 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$11.61 - $31.21 $1.28 Million - $3.45 Million
110,410
110,410 $3.45 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.1B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.